-
L654977-1mlLP-935509 is an orally active, potent, selective, ATP-competitive and brain-penetrant inhibitor of adaptor protein-2 associated kinase 1 (AAK1) with an IC 50 of 3.3 nM and a K i of 0.9 nM, respectively. LP-935509 is also a potent inhibitor of BIKE (
-
L649176-100mgLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L649176-10mgLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L649176-1mgLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L649176-25mgLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L649176-50mgLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L649176-5mgLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L655738-1mlLp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease researchIn VitroLipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2
-
L651274-100mgLp-PLA2-IN-3 is a potent and orally bioavailable lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC 50 of 14 nM for recombinant human Lp-PLA2 (rhLpPLA2).In VivoLp-PLA2-IN-3 (3 mg/kg: p.o.) treatment shows the C max , AUC 0-24h ,
-
L651274-10mgLp-PLA2-IN-3 is a potent and orally bioavailable lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC 50 of 14 nM for recombinant human Lp-PLA2 (rhLpPLA2).In VivoLp-PLA2-IN-3 (3 mg/kg: p.o.) treatment shows the C max , AUC 0-24h ,
-
L651274-50mgLp-PLA2-IN-3 is a potent and orally bioavailable lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC 50 of 14 nM for recombinant human Lp-PLA2 (rhLpPLA2).In VivoLp-PLA2-IN-3 (3 mg/kg: p.o.) treatment shows the C max , AUC 0-24h ,
-
L651274-5mgLp-PLA2-IN-3 is a potent and orally bioavailable lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC 50 of 14 nM for recombinant human Lp-PLA2 (rhLpPLA2).In VivoLp-PLA2-IN-3 (3 mg/kg: p.o.) treatment shows the C max , AUC 0-24h ,